(Q34270746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

P Vici

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

17 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-003-0498-7

20 December 2019

exact match

0 references

cites work

Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive rats

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats

1 reference

12 December 2020

A pharmacoeconomic evaluation of the use of dexrazoxane in preventing anthracycline-induced cardiotoxicity in patients with stage IIIB or IV metastatic breast cancer

1 reference

12 December 2020

The role of iron and iron chelators in anthracycline cardiotoxicity

1 reference

12 December 2020

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

12 December 2020

Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity

1 reference

12 December 2020

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

1 reference

12 December 2020

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

1 reference

12 December 2020

Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.

1 reference

12 December 2020

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

12 December 2020

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

12 December 2020

Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique

1 reference

12 December 2020

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

1 reference

12 December 2020

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562

1 reference

12 December 2020

Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas

1 reference

12 December 2020

Cardiomyopathy Caused by Antineoplastic Therapies

1 reference

12 December 2020

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.

1 reference

12 December 2020

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

1 reference

12 December 2020

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

12 December 2020

Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle

1 reference

12 December 2020

The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin

1 reference

12 December 2020

Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats

1 reference

12 December 2020

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Phase II trial of ICRF-187 in children with solid tumors and acute leukemia

1 reference

12 December 2020

Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results

1 reference

12 December 2020

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

12 December 2020

Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials

1 reference

12 December 2020

Pharmacokinetics of (+)-1,2-di(3,5-dioxopiperazin-1-yl)propane intravenous infusions in adult cancer patients

1 reference

12 December 2020

Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group

1 reference

12 December 2020

10.1007/S00432-003-0498-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564513%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference